lung in Biological Technology
Navigation Links
lung in Biological Technology
... Phase 3 SPEAR trial of picoplatin in small cell lung cancer in the fourth quarter of 2009 with the ... the pivotal Phase 3 SPEAR trial in small cell lung cancer (SCLC) in the fourth quarter of 2009;
... picoplatin include a Phase 3 trial in small cell lung cancer and Phase 2 trials in metastatic ...
... patients with nontuberculous mycobacteria (NTM) lung infections. Transave and NIAID will ... trial to evaluate ARIKACE in patients with NTM lung disease who have failed to respond to standard, ... MD. "This is the third type of chronic lung infection for which ARIKACE is being evaluated," ...
... BDP) decreases non-infectious inflammation of the lung in acute gastrointestinal Graft-versus-Host ... (HCT). Non-infectious inflammation of the lung is a common and potentially fatal complication of ... exchange of oxygen and carbon dioxide between the lung and blood and, in its severe form, may present as ...
... L-DOS47, a Novel Candidate for the Treatment of lung Adenocarcinoma" provides a summary of the ... of the lung, the most common form of lung cancer in the world today. L-DOS47 is thought to ... to modify the microenvironmental conditions of lung cancer cells in a manner that leads to their ...
... multi-center Phase 2 trial in non-small cell lung cancer (NSCLC) with its novel, first-in-class, ... of clinical laboratory, electrocardiograms, lung function, and adverse events. The trial was ... colon cancer where, unlike the non-small cell lung cancer study design, perifosine is dosed 50mg or ...
... ongoing clinical studies in prostate, brain and lung cancers were among the data presented on AT-101, ... primary endpoint, is ongoing. AT-101 in lung Cancer Reports from two studies in lung cancer also showed promising signals of antitumor ...
... in patients with stage IIIB/IV non-small cell lung cancer, preliminary results from the Phase 1 ... in patients with stage IIIb/IV non-small cell lung cancer (NSCLC) were studied. Ten of these ... MUC1 is over-expressed on many cancers such as lung cancer, breast cancer, prostate cancer and ...
... A 71-year old man with inoperable lung cancer is able to receive stereotactic body ... surgery was not an option for removing his lung tumor. To treat the tumor, Arul Mahadevan, MD, ... as much as possible, the delicate healthy lung tissues around it. To further ensure treatment ...
... Hall F3 lung Cancer A Phase 2 Study of ... with Locally Advanced/Metastatic Non-Small Cell lung Cancer Joline S. Lind, M.D., ... including breast cancer, colorectal cancer, lung cancer, ovarian cancer, and as an adjuvant ...
... Association between SpCO and Measures of lung Function IRVINE, Calif., May 13 ... was an associated 79% proportionate decrease in lung function (%FEV1, p=0.015) and a trend indicating SpCO may predict lung function after 2-hours of treatment, as measured ...
... safety of picoplatin in patients with small cell lung cancer (SCLC) who were refractory to or ... the second half of 2009. About Small Cell lung Cancer SCLC is the most aggressive form of lung cancer and tends to be widespread by the time of ...
... II clinical trial in patients with non-small cell lung cancer (NSCLC). The open-label, Simon two-stage ... promising early results from this pilot Phase II lung cancer trial and will now move forward to ... Good Clinical Practices (GCP) guidelines. lung cancer is a major cause of cancer deaths ...
... for the treatment of advanced non-small cell lung cancer (NSCLC). At two years, 30% of patients who ... in various cancers." Non-Small Cell lung Cancer Phase 1/2 Study Design with Updated ... undifferentiated or unspecified non-small cell lung cancer. The primary objectives of the study were ...
... in approximately 128 patients with non-small cell lung cancer (NSCLC) and a Phase II trial in ... other EGFR-targeting drugs." Non-small cell lung cancer trial This randomized, double-blind, ... among patients with metastatic non-small-cell lung cancer. Int J Radiat Oncol Biol Phys ...
... from several types of carcinomas in the lung with such high level of accuracy" noted Harvey ... Medical Center. "Ruling out Mesothelioma from lung cancer for individuals that were exposed to ... between two subtypes of non small cell lung cancer (NSCLC). This diagnosis is important ...
... A Custom Molecular Phenotyping Assay for lung Disease FREMONT, Calif., Oct. 30 ... novel gene expression research in the area of lung disease involving WaferGen's SmartChip(TM) ... M.D., will apply gene expression profiling to lung samples from patients with chronic obstructive ...
... symptoms, smoking history and age. About the lung Function Questionnaire Data was also presented ... States. COPD is a progressive, life- threatening lung disease that includes chronic bronchitis and ... by airflow obstruction, a limitation in lung function that makes it difficult to breathe. Many ...
... Planned Cohort of 21 Patients with Non-Small Cell lung Cancer Enrolled in First Stage of Trial ... and paclitaxel in patients with non-small cell lung cancer (NSCLC). The primary objective of the ... and Good Clinical Practices (GCP) standards. lung cancer is a major cause of cancer deaths ...
Oncothyreon announces presentation of long-term Stimuvax data at World Conference on Lung Cancer
... at the International Association for the Study of lung Cancer's 13th World Conference on lung Cancer in San Francisco on August 1, 2009. The ... in patients with stage IIIb/IV non-small cell lung cancer (NSCLC). As of the time of data analysis ...... patients with nontuberculous mycobacteria (NTM) lung infections. Transave and NIAID will ... trial to evaluate ARIKACE in patients with NTM lung disease who have failed to respond to standard, ... MD. "This is the third type of chronic lung infection for which ARIKACE is being evaluated," ...
New Report Just Published: World Prostate Cancer Therapeutics Market Report
... (2007): Percentage Breakdown by Cancer Type - lung & Bronchus, Prostate, Colon & Rectum, ... Immunotoxin for Treatment of Prostate and lung Cancer II-66 Barr Unveils Generic Version of ... (2007): Percentage Breakdown by Cancer Type - lung & Bronchus, Prostate, Colon & Rectum, ...... BDP) decreases non-infectious inflammation of the lung in acute gastrointestinal Graft-versus-Host ... (HCT). Non-infectious inflammation of the lung is a common and potentially fatal complication of ... exchange of oxygen and carbon dioxide between the lung and blood and, in its severe form, may present as ...
... L-DOS47, a Novel Candidate for the Treatment of lung Adenocarcinoma" provides a summary of the ... of the lung, the most common form of lung cancer in the world today. L-DOS47 is thought to ... to modify the microenvironmental conditions of lung cancer cells in a manner that leads to their ...
Phase 3 Cystic Fibrosis Trial Results Presented at European Conference
... trial was to assess whether Bronchitol improves lung function as measured by a change in FEV1 when ... was to assess whether Bronchitol further improves lung function in patients already being treated with ... an immediate and sustained improvement in lung function (FEV1) over the 26 weeks ...... multi-center Phase 2 trial in non-small cell lung cancer (NSCLC) with its novel, first-in-class, ... of clinical laboratory, electrocardiograms, lung function, and adverse events. The trial was ... colon cancer where, unlike the non-small cell lung cancer study design, perifosine is dosed 50mg or ...
... ongoing clinical studies in prostate, brain and lung cancers were among the data presented on AT-101, ... primary endpoint, is ongoing. AT-101 in lung Cancer Reports from two studies in lung cancer also showed promising signals of antitumor ...
... in patients with stage IIIB/IV non-small cell lung cancer, preliminary results from the Phase 1 ... in patients with stage IIIb/IV non-small cell lung cancer (NSCLC) were studied. Ten of these ... MUC1 is over-expressed on many cancers such as lung cancer, breast cancer, prostate cancer and ...
... A 71-year old man with inoperable lung cancer is able to receive stereotactic body ... surgery was not an option for removing his lung tumor. To treat the tumor, Arul Mahadevan, MD, ... as much as possible, the delicate healthy lung tissues around it. To further ensure treatment ...
... Hall F3 lung Cancer A Phase 2 Study of ... with Locally Advanced/Metastatic Non-Small Cell lung Cancer Joline S. Lind, M.D., ... including breast cancer, colorectal cancer, lung cancer, ovarian cancer, and as an adjuvant ...
... Association between SpCO and Measures of lung Function IRVINE, Calif., May 13 ... was an associated 79% proportionate decrease in lung function (%FEV1, p=0.015) and a trend indicating SpCO may predict lung function after 2-hours of treatment, as measured ...
Lilly Set to Unveil More Than 50 Studies at ASCO 2009
... "With ASCO studies focusing on non-small cell lung cancer, breast cancer, cervical cancer and ... phase III study in advanced non-small cell lung cancer This study is being presented ... as First-line Therapy for Advanced Non-Small Cell lung Cancer Abstract #8045: ...... safety of picoplatin in patients with small cell lung cancer (SCLC) who were refractory to or ... the second half of 2009. About Small Cell lung Cancer SCLC is the most aggressive form of lung cancer and tends to be widespread by the time of ...
Allegro Diagnostics Expands Board and Executive Team
... leader in the field of molecular diagnostics for lung cancer, has announced that Stephen Chubb has ... leader in the field of molecular diagnostics for lung cancer, has announced that Stephen Chubb has ... most effective ways to reduce deaths from lung cancer are to detect it earlier and identify, ...Cell Therapeutics Presents Corporate Highlights at Invest Northwest Conference
... (NHL) and OPAXIO for treatment of non-small cell lung cancer, including: Shared ... Reviewed OPAXIO data in small cell lung cancer and the status of the ongoing phase III ... of relapsed aggressive NHL, non-small cell lung cancer and ovarian cancer, determinations by ...Angiotech announces positive results from Bio-Seal(TM) clinical study
... clinical study results for its Bio-Seal(TM) lung Biopsy Tract Plug System at the Society of ... and efficacy of Bio-Seal in patients undergoing lung biopsy procedures and demonstrated a ... improves the existing technology used to diagnose lung cancer by significantly reducing the rates of ...FDA Approves SYMBICORT(R) for Chronic Obstructive Pulmonary Disease (COPD)
... for millions of Americans with debilitating lung disease WILMINGTON, Del., Feb. 27 ... which found SYMBICORT significantly improved lung function within five minutes of the first dose(1) and sustained that lung function improvement for the duration of the ...Implicit Licenses Clinical Stage Antibody Program From Lilly
... to develop this promising drug to treat acute lung injury (ALI) caused by a dysregulated immune ... and commercialisation. About Acute lung Injury Acute lung injury (ALI) is a severe inflammatory disease ...... II clinical trial in patients with non-small cell lung cancer (NSCLC). The open-label, Simon two-stage ... promising early results from this pilot Phase II lung cancer trial and will now move forward to ... Good Clinical Practices (GCP) guidelines. lung cancer is a major cause of cancer deaths ...
... for the treatment of advanced non-small cell lung cancer (NSCLC). At two years, 30% of patients who ... in various cancers." Non-Small Cell lung Cancer Phase 1/2 Study Design with Updated ... undifferentiated or unspecified non-small cell lung cancer. The primary objectives of the study were ...
InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF
... In CAPACITY 2, 83% and 90% of surviving, lung transplant-free patients completed therapy per ... in the overall treatment effect of pirfenidone on lung function and exercise tolerance. In addition, ... IPF patients with mild to moderate impairment in lung function. The primary endpoint of both trials ...Chronic Lung Disease - Axentis Pharma Attracts Investment Interest
... new therapeutic formulation for treating chronic lung disease at the 2nd Annual European Life Science ... uses biocompatible lipids endogenous to the lung that are formulated into small liposomes. ... increased secretion deposits on mucous membranes. lung complications represent the most serious ...Rosetta Genomics Announces Exclusive Distribution Agreement With Teva Pharmaceutical Industries Ltd.
... squamous from non-squamous, non-small cell lung cancer (NSCLC) patients. When administered ... patients with squamous cell carcinoma of the lung have demonstrated varying response patterns ... squamous from non-squamous non-small cell lung cancer are not standardized, are difficult to ...... in approximately 128 patients with non-small cell lung cancer (NSCLC) and a Phase II trial in ... other EGFR-targeting drugs." Non-small cell lung cancer trial This randomized, double-blind, ... among patients with metastatic non-small-cell lung cancer. Int J Radiat Oncol Biol Phys ...
... from several types of carcinomas in the lung with such high level of accuracy" noted Harvey ... Medical Center. "Ruling out Mesothelioma from lung cancer for individuals that were exposed to ... between two subtypes of non small cell lung cancer (NSCLC). This diagnosis is important ...
38 Cryoablation Studies, Exhibits Presented at National Radiological Society Meeting
... effectiveness of cryoablation for treating liver, lung and brain cancers, as well as an immunologic ... to cryoablation as a treatment for bone pain, lung and kidney cancers, in addition to the more ... the ablation of tumors in the kidney, lung and liver and palliative intervention (treatment ...China Medical Technologies Completes the Development of EGFR Molecular Diagnostic Kits
... of molecular diagnostic kits for non-small cell lung cancer therapy," said Mr. Xiaodong Wu, ... with significant market potential." lung cancer is one of the most common cancers in the ... China. It is estimated that more than 500,000 new lung cancer cases were diagnosed each year in China ...... A Custom Molecular Phenotyping Assay for lung Disease FREMONT, Calif., Oct. 30 ... novel gene expression research in the area of lung disease involving WaferGen's SmartChip(TM) ... M.D., will apply gene expression profiling to lung samples from patients with chronic obstructive ...
... symptoms, smoking history and age. About the lung Function Questionnaire Data was also presented ... States. COPD is a progressive, life- threatening lung disease that includes chronic bronchitis and ... by airflow obstruction, a limitation in lung function that makes it difficult to breathe. Many ...
Unraveling the genetic picture of lung cancer
... pathways activated in the most common form of lung cancer lung adenocarcinoma and could lead to improved ... play a significant role in the development of lung adenocarcinoma as well as cellular pathways ...Large-scale genetic study sheds new light on lung cancer
... changes involved in the most common form of lung cancer, lung adenocarcinoma. The findings should help pave the ... 26 genes that are frequently mutated in lung adenocarcinoma -- an achievement that more than ...... Planned Cohort of 21 Patients with Non-Small Cell lung Cancer Enrolled in First Stage of Trial ... and paclitaxel in patients with non-small cell lung cancer (NSCLC). The primary objective of the ... and Good Clinical Practices (GCP) standards. lung cancer is a major cause of cancer deaths ...
Lilly to Acquire ImClone Systems in $6.5 Billion Transaction
... head and neck, colorectal and non-small cell lung cancer. Given that three of ImClone's pipeline ... therapy Pulmonary Toxicity -- Interstitial lung disease (ILD), which was fatal in one ... treatment of advanced nonsquamous non-small cell lung cancer (NSCLC), a specific type of NSCLC. ALIMTA ...Pharmaxis Research Programs Highlighted at European Respiratory Society Congress
... symposiums and poster sessions relating to the lung challenge product, Aridol, and the mucus clearing ... for everyday practice -- Infectious lung diseases including tuberculosis -- A ... for important improvements in the treatment of lung diseases. Full details of ERS may be viewed on ...Transave, Inc. Secures $12.5 Million in New Financing
... for the site-specific treatment of serious lung diseases, today announced that it has secured a ... GmbH), produced a significant improvement in lung function, was well-tolerated, and had a ... in the treatment of Pseudomonas aeruginosa, a lung infection common in cystic fibrosis ....Researchers develop new model for cystic fibrosis
... of death and disability in patients with CF is lung disease. However, many questions remain about how infection and inflammation leads to lung damage. In the study, the lungs of the newborn CF ... researchers hope to learn more about how and why lung disease develops in patients with CF. ...Pigs bred with cystic fibrosis provide model to mimic human disease
... disease in Caucasians - often die because of a lung disease developed later. Scientists have been ... develop an animal model that develops the fatal lung disease. Now, a University of Missouri researcher ... continue to mimic the human symptoms so the fatal lung disease can be studied and ultimately treated. ...33rd ESMO Congress in Stockholm, 12-16 September 2008
... drugs over the past 10 years in 27 countries. lung Cancer Significant benefits in non-small-cell lung cancer from customising treatment (Embargoed until Saturday 13 September 2008, 12:45 CEST) lung cancer patients whose tumours carry specific ...Other ContentsbreechbreechbrokenbrokenbrokenbrokenbrokenbrokennailsnailsbrittlebrittlebrittlebroadbroadbroadbroadbroadbroadbroadbroadbroadbroadbronchiectasisbronchitisbronchitisbronchitisbronchoscopybronchoscopyOther Tagsturtlefallfallfall
(Date:12/14/2009)... WAYNE, Pa., Dec. 14 MODA Technology ... monitoring (EM), utility and product testing for the ... MODA 3.0, the company,s third generation mobile data ... (QC) organizations to further automate their regulated manufacturing ... new capabilities: ,, Fully-Configurable Test Methods: ...
(Date:12/13/2009)... resolved a question about how a popular class ... biosensors that reveal previously hidden components of chemical ... and hallucinations characterize the illness, people with schizophrenia ... in a particular order, difficulties that interfere with ... well, said Lee Schroeder, a student in the ...
(Date:12/13/2009)... 10, 2009Researchers at The Scripps Research Institute have ... protein from an ancient family of enzymes can ... In addition to providing guidance for understanding other ... theoretical underpinning for the protein,s possible use for ... The research was published in the December 13, ...
Breaking Biology News(10 mins):MODA Announces Availability of Third Generation Mobile Data Acquisition Platform 2New biosensors reveal workings of anti-psychotic drugs in the living brain 2Scripps Research scientists crack mystery of protein's dual function 2Scripps Research scientists crack mystery of protein's dual function 3Provocative New Fiction Makes for a Fascinating Fast Paced Read 13713 1Provocative New Fiction Makes for a Fascinating Fast Paced Read 13713 2LiveProcess Implements Emergency Management Platform with 51 Florida Hospitals 55482 1LiveProcess Implements Emergency Management Platform with 51 Florida Hospitals 55482 2SYNAPT G2s Power Versatility and Speed Headlines Comprehensive Portfolio of Mass Spectrometers at IMSC 55479 1SYNAPT G2s Power Versatility and Speed Headlines Comprehensive Portfolio of Mass Spectrometers at IMSC 55479 2SYNAPT G2s Power Versatility and Speed Headlines Comprehensive Portfolio of Mass Spectrometers at IMSC 55479 3SYNAPT G2s Power Versatility and Speed Headlines Comprehensive Portfolio of Mass Spectrometers at IMSC 55479 4SYNAPT G2s Power Versatility and Speed Headlines Comprehensive Portfolio of Mass Spectrometers at IMSC 55479 5(Date:12/15/2009)... -- Hosted by the Technology-based Learning SIG of ... 2009,s best eLearning designs. This year nominees, ... categories. The Venza Group entry, a highly ... hotelier, was selected as the winner of the ... by the panel of distinguished judges. While ...
(Date:12/15/2009)... CLARA, Calif., Dec. 15 Today, ... into Santa Clara County for the first ... Effective immediately, Coastal Healthcare Administrators will be ... by the Physicians Foundation for Medical Care. ... healthcare philosophy, Coastal maintains close working relationships ...
(Date:12/15/2009)... with hormones, but when the tumours start growing again ... thesis from the Sahlgrenska Academy, at the University of ... treatments for hormone-resistant prostate cancer. , Late in the ... spread, most patients are given hormone therapy. This reduces ... tumour shrinks. , "The problem is that the effect ...
(Date:12/15/2009)... A new study published by The University of ... for paid and unpaid work report higher average measures ... family models. , The ,shared roles, category, where each ... the total unpaid work, is a growing category that ... Couples are more likely to be in a shared ...
(Date:12/15/2009)... 2009) Although seen as a potential heart ... inhibiting activity of a transfer protein may not be ... Mayer USDA Human Nutrition Research Center on Aging (USDA ... of Medicine found an association between low plasma cholesterol ... heart disease in the Framingham Heart Study population. , ...
Breaking Medicine News(10 mins):Health News:The Venza Group Received Top Honors at the American Society of Training & Development (ASTD) eLearning Excellence Awards Ceremony Held on December 10, 2009 2Health News:Coastal Healthcare Administrators Expands Provider Network to Santa Clara County 2Health News:More blood vessels in hormone-resistant prostate tumors 2Health News:Low cholesterol transfer protein activity associated with heart disease risk 2[0] The Venza Group Received Top Honors at the American Society of Training & Development (ASTD) eLearning Excellence Awards Ceremony Held on December 10, 2009[0] Coastal Healthcare Administrators Expands Provider Network to Santa Clara County[0] More blood vessels in hormone-resistant prostate tumors[0] Couples who do the dishes together stay happier[0] Low cholesterol transfer protein activity associated with heart disease risk
SalvadorturtledeformityillustrateenvironmentsmetagenomicsjunkylengthenexpectanciesillustratedMayrsystematicAthensfall
Other Tagsreinforces 2reinforces 3cholesterol 2cholesterol 3cholesterol 4tools 2tools 3tools 4tools 5tools 6tools 7tools 8tools 9tools 10need 2need 3need 4need 5need 6need 7need 8need 9need 10addresses 2symposium 2| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |